About half of health care workers positive for COVID-19 by serology have no symptoms

  • The IVY Research Network has completed initial studies evaluating the epidemiology of COVID-19 in health care workers and patients.

Nashville, Tennessee, USA (July 9, 2020) — Among 249 front-line health care workers who cared for COVID-19 patients during the first month of the pandemic in Tennessee, 8% tested positive for COVID-19 antibodies by serology testing, suggesting they had contracted COVID-19 in the first several weeks of taking care of COVID-19 patients. Among these health care workers with positive serology results, 42% reported no symptoms of a respiratory illness in the prior two months. This suggests that front-line health care workers are at high risk for COVID-19 and that many health care workers with the virus may not have typical symptoms of a respiratory infection. These results were published in the journal Clinical Infectious Diseases on July 6.

„Our results suggest that screening health care workers for COVID-19 even when they don’t have any symptoms could be important to prevent the spread of the virus within hospitals,“ said Wesley Self, MD, associate professor of Emergency Medicine at Vanderbilt University Medical Center and lead investigator for the IVY Network.

Investigator Bo Stubblefield, MD, instructor of Emergency Medicine, added, „We are continuing to study COVID-19 in front-line health care workers across the country to better understand what may be done to decrease their risk of infection, such as using specific types of personal protective equipment.“

In a separate study, the IVY investigators studied 350 patients across 11 medical centers in the U.S. who tested positive for COVID-19; 54% of these patients reported no close contact with another person known to have COVID-19 in the two weeks before getting sick.

„With over half of COVID-19 patients not identifying a clear source of their infection, this study reinforces the need for practical measures to reduce the spread of the virus, such as social distancing and the use of face coverings when out in public,“ Self said.

Additionally, 40% of COVID-19 patients in the study remained symptomatic two weeks after a positive COVID-19 test, showing that patients with COVID-19 tend to remain ill longer than with other respiratory infections, such as influenza. The results were published by the journal Morbidity and Mortality Weekly Report on June 30.

The IVY Network is a collaborative research group of multiple medical centers in the U.S led by Vanderbilt University Medical Center. It is funded by Centers of Disease Control and Prevention (CDC) to conduct research on severe respiratory infections, including COVID-19 and influenza.

 

 


Vanderbilt University Medical Center, 09.07.2020 (tB).

Schlagwörter:

MEDICAL NEWS

New guidance to prevent the tragedy of unrecognized esophageal intubation
Overly restrictive salt intake may worsen outcomes for common form…
COVID-19 vaccines are estimated to have prevanented 20 million deaths…
Novel sleep education learning modules developed for nurse practitioners
Scientists discover how salt in tumours could help diagnose and…

SCHMERZ PAINCARE

Aktuelle Versorgungssituation der Opioidtherapie im Fokus
Individuelle Schmerztherapie mit Opioiden: Patienten im Mittelpunkt
Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…

DIABETES

Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT
„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Kaltplasma bei diabetischem Fußsyndrom wirkt via Wachstumsfaktoren
Typ-1-Diabetes: InRange – auf die Zeit im Zielbereich kommt es…

ERNÄHRUNG

Gesunde Ernährung: „Nicht das Salz und nicht das Fett verteufeln“
Mangelernährung gefährdet den Behandlungserfolg — DGEM: Ernährungsscreening sollte zur klinischen…
Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?

ONKOLOGIE

Nahrungsergänzungsmittel während der Krebstherapie: Es braucht mehr Bewusstsein für mögliche…
Fusobakterien und Krebs
Fortgeschrittenes Zervixkarzinom: Pembrolizumab verlängert Leben
Krebspatienten unter Immuntherapie: Kein Hinweis auf erhöhtes Risiko für schwere…
Aktuelle Kongressdaten zum metastasierten Mammakarzinom und kolorektalen Karzinom sowie Neues…

MULTIPLE SKLEROSE

Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?
Neuer Therapieansatz für Multiple Sklerose und Alzheimer
„Ich messe meine Multiple Sklerose selbst!“ – Digitales Selbstmonitoring der…

PARKINSON

Alexa, bekomme ich Parkinson?
Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…